Daclatasvir

J - Antiinfectives For Systemic Use -> J05 - Antivirals For Systemic Use -> J05A - Direct Acting Antivirals -> J05AX - Other Antivirals -> J05AX14 - Daclatasvir
Administration category: Free Medicine group: antiviral Brand name: Daklinza

Standard dosages

≥ 18 years
WeightROALoadDosage
ROA:
po
Load:
-
Dosage:
60mg 1 dd

Kidney function

Renal elimination: 6.6%
Dosage: independent on kidney function

Interactions

Interaction with (ATC): Interaction with: Expected effect:
Interaction with (ATC):
J05AG03 - Efavirenz
Interaction with:
Expected effect:
dosering daclatasvir naar 1 dd 90 mg
Interaction with (ATC):
J05AG01 - Nevirapine
Interaction with:
Expected effect:
dosering daclatasvir naar 1 dd 90 mg
Interaction with (ATC):
J05AG04 - Etravirine
Interaction with:
Expected effect:
dosering daclatasvir naar 1 dd 90 mg
Interaction with (ATC):
Interaction with:
Sterke CYP3A4 remmer
Expected effect:
dosering daclatasvir naar 1 dd 30 mg

Pregnancy

Due to the expiration of the alphanumeric classification for use in pregnancy and lactation, reference is made to the current, online information of the Teratology Information Service (TIS) of LAREB:

For individual advice, consult an expert on site.
Metadata

Swab vid: M-287669.1
Updated: 06/16/2019 - 20:05
Status: Published

External links
Menu position